My watch list  

905 Current news from the ressort finances


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
BioNTech to Raise USD 250 Million in Private Placement

The private placement includes an investment in ordinary shares and a investment in 4-year mandatory convertible notes


BioNTech SE announced a private investment of USD 250 million (EUR 223 million) by Temasek and other accredited investors. The private placement includes an investment of approximately USD 139 million in ordinary shares and a USD 112 million investment in 4-year mandatory convertible notes. “We ...


image description
Bit Bio secures $41.5 million of funding from top life sciences investors

Bit Bio’s aim is to decode “cellular identity” in order to generate every cell type of the human body


Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells for the wellbeing of humanity, announced the close of a $41.5 million Series A investment, bringing the company’s total funding to $50 million. In a strong statement of support for the company’s ...


image description
German Federal Government invests 300 Million Euros in CureVac

Federal Government will not influence corporate policy decisions


The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH & Co. KG, announced today that the Federal Republic of Germany will invest 300 million Euros in the ...


image description
Covid-19 research in wastewater

Biobot Analytics Raises $6.7 Million in Seed Funding to Transform Wastewater Infrastructure into Public Health Observatories


Biobot Analytics, atechnology company that deploys wastewater monitoring equipment and analytical tools to provide novel public health insights at the community level, announced it has raised $4.2 million bringing its total amount of seed funding to $6.7 million. In response to the crisis, ...


APEIRON Biologics announces financing round for the further development of the COVID-19 drug APN01

Financing secures further clinical trials and the supply of material for the treatment of COVID-19 patients


APEIRON Biologics AG will complete a capital increase to finance the further development of APN01 for the treatment of severely ill COVID-19 patients as well as the development of immuno-oncology projects. The Vienna Insurance Group (VIG) will lead the financing round and secures the private ...


image description
3D printer for medicine

Kumovis closes Series A funding led by Renolit and Solvay


Kumovis, the developer of the world’s first 3D printer with clean room integration, announced that it has raised a €3.6 million Series A funding round. In Renolit SE and Solvay Ventures, the Munich-based start-up has found two additional partners on its way to establish industrial additive ...


image description
Drug discovery with artificial intelligence

Evotec participates in Exscientia's financing round


Evotec SE announced that the Company has participated in the Series C funding round of Exscientia, the Artificial Intelligence (AI)-driven drug discovery company. The funding round led by new investor Novo Holdings raised $ 60 m with the existing investors’ consortium consisting of Evotec, ...


image description
Start-up Raises 16.3 million Euros to Prepare Market Launch of its SARS-CoV-2 Rapid Testing System

“Mini-laboratory” provides test results in 30 to 40 minutes


Spindiag GmbH, a medical technology start-up company founded four years ago as a spin-off of the Hahn-Schickard Institute for Microanalytical Systems, announced the completion of a 16.3 million Euros (USD 17.8 million) Series B financing round as expected. Existing investors as well as ...


Marinomed receives funding to research SARS-CoV-2 therapy


Marinomed Biotech AG receives funding from the Austrian Research Promotion Agency (FFG) for the development of a SARS-CoV-2 therapy based on Carragelose®. The aim of the project is to clinically test an inhalation solution as an acute treatment for viral pneumonia caused by SARS-CoV-2 or other ...


Bayer: Good start to 2020

Activities marked by COVID-19


The Bayer Group has registered a good start to 2020, with business activities in the first quarter greatly marked by the COVID-19 pandemic. “With our life science product portfolio in the areas of health and nutrition, we have shown our ability to successfully continue our business operations in ...


Page 1 From 91
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE